Metoclopramide Hcl Cf (Metoclopramide Hydrochloride)

The drug blocks dopamine D2 receptors in the chemoreceptor trigger zone of the brain, reducing the stimulus for nausea. It also stimulates gastrointestinal motility by antagonising D2 receptors in the gut, and at higher doses it blocks serotonin (5‑HT3) receptors, adding to its anti‑emetic effect.

The appropriate dose of Metoclopramide is individualized by the prescribing clinician based on the specific indication, patient age, renal function, and overall clinical condition. No fixed regimen is provided here; the prescriber sets the dosage and duration.

Safety data for metoclopramide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metoclopramide differs from many antiemetics by combining dopamine antagonism with pro‑kinetic activity, making it useful for both nausea control and gastric emptying. Other agents such as ondansetron act primarily on serotonin receptors and lack the pro‑kinetic effect, while antihistamines may cause more sedation.

Store the oral tablets at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and light, and avoid storing it in areas with high humidity or direct sunlight.

Metoclopramide Hcl Cf is supplied as oral tablets that are taken by mouth with or without food, as directed by a healthcare professional. The exact timing relative to meals or other medications should follow the prescriber's instructions.

Serious adverse events include extrapyramidal reactions such as acute dystonia, the development of tardive dyskinesia with long‑term use, and rare cases of neuroleptic malignant syndrome. Patients should seek immediate medical attention if they experience uncontrolled muscle movements, severe rigidity, fever, or altered mental status.

Metoclopramide is contraindicated in individuals with known hypersensitivity to the drug, those with pheochromocytoma, and patients with a history of seizure disorders unless benefits outweigh risks. Caution is also advised for patients with severe depression, Parkinson’s disease, or gastrointestinal obstruction.